Jiguang Han - Concepedia

Author

Jiguang Han

Harbin Medical University ORCID

Also Known As

H. Yoo, J. Han, J.-Y. Han, Ji-Guang Han, Ji-guang Han, Jiguang Han

Publications

632

Citations

H-Index

Concepts

All Affiliations

Harbin Medical University Third Affiliated Hospital of Harbin Medical University Second Affiliated Hospital of Harbin Medical University First Affiliated Hospital of Harbin Medical University

About

Jiguang Han is an author at Harbin Medical University specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	360
2	Cell Biology	2	2	266
3	Health Sciences	1	1	140
4	Public Health	1	1	29
5	Epidemiology	1	1	29

Jiguang Han

Publications

600

Citations

H-Index

Page 1

	Year	Citations
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma Ruiqi Liu, Yuejin Li, Lantian Tian, Cancer Letters Tumor BiologyHealth SciencesHuman Hepatocellular CarcinomaMetabolic ReprogrammingMedicine	2018	140
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway Jiguang Han, Baojuan Han, Xueya Wu, Toxicology and Applied Pharmacology Breast OncologyLncrna H19MedicineCancer BiologyBreast Cancer	2018	126
Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer Zhigang Ma, Jie Lian, Ming Yang, Pathology - Research and Practice MedicinePathologyColorectal CancerPoor PrognosisMolecular Pathology	2019	65
Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer Rui Huang, Jiguang Han, Xiaoshuan Liang, Cellular Physiology and Biochemistry	2017	42
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer Ming Zhang, Xiao-dan Teng, Xinxin Guo, The Breast	2012	39
MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Frizzled 5 expression Feng Liu, Yang Liu, Jingling Shen, Oncotarget	2016	39
Long-term follow-up in the KEYNOTE-010 study of pembrolizumab (pembro) for advanced NSCLC, including in patients (pts) who completed 2 years of pembro and pts who received a second course of pembro Roy S. Herbst, Edward B. Garon, D.-W. Kim, Annals of Oncology	2018	33
Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province Yongdong Jiang, Jiguang Han, Jing Liu, Breast Cancer Research and Treatment Genome-wide Association StudyGenetic VariantsCancer RiskMedicineGenetics	2010	29
Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer Tian Tian, Jiguang Han, Jian Huang, Frontiers in Oncology	2021	26
Clinicopathologic characteristics and prognosis of young patients with breast cancer Jiguang Han, Yongdong Jiang, Chunhui Zhang, The Breast	2011	25

Page 1